{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T21:15:02Z","timestamp":1775596502556,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973397"],"award-info":[{"award-number":["81973397"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.cbi.2019.108840","type":"journal-article","created":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T11:12:21Z","timestamp":1569928341000},"page":"108840","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Effects of 24 CYP2D6 variants found in Chinese population on the metabolism of clonidine in vitro"],"prefix":"10.1016","volume":"313","author":[{"given":"Xiang-yu","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-xia","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-jing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-ping","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-xin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cbi.2019.108840_bib1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pediatrneurol.2012.05.002","article-title":"Prevalence of tic disorders: a systematic review and meta-analysis","volume":"47","author":"Knight","year":"2012","journal-title":"Pediatr. Neurol."},{"issue":"5","key":"10.1016\/j.cbi.2019.108840_bib2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/archdischild-2011-300585","article-title":"The gilles de la tourette syndrome: the current status","volume":"97","author":"Robertson","year":"2012","journal-title":"Arch. Dis. Child. Educ. Pract. Ed."},{"issue":"1","key":"10.1016\/j.cbi.2019.108840_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s40263-017-0486-0","article-title":"Current approaches and new developments in the pharmacological management of tourette syndrome","volume":"32","author":"Quezada","year":"2018","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.cbi.2019.108840_bib4","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.psychres.2013.10.009","article-title":"Clonidine in tourette syndrome and sensorimotor gating","volume":"215","author":"Eapen","year":"2014","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.cbi.2019.108840_bib5","first-page":"80","article-title":"Clinical observation on treatment of tourette syndrome in Chinese children by clonidine adhesive patch","volume":"20","author":"Jiao","year":"2016","journal-title":"Eur. J. Paediatr. Neurol.: EJPN: Off. J. Eur. Paediatr. Neuro. Soc."},{"issue":"4","key":"10.1016\/j.cbi.2019.108840_bib6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1155\/2013\/626410","article-title":"Trials of pharmacological interventions for tourette syndrome: a systematic review","volume":"26","author":"Waldon","year":"2013","journal-title":"Behav. Neurol."},{"issue":"5","key":"10.1016\/j.cbi.2019.108840_bib7","first-page":"421","article-title":"Tourette syndrome and comorbid adhd: current pharmacological treatment options","volume":"17","author":"Rizzo","year":"2013","journal-title":"Eur. J. Paediatr. Neurol.: EJPN: Off. J. Eur. Paediatr. Neuro. Soc."},{"issue":"9","key":"10.1016\/j.cbi.2019.108840_bib8","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/jcpp.12556","article-title":"Practitioner review: treatments for tourette syndrome in children and young people - a systematic review","volume":"57","author":"Whittington","year":"2016","journal-title":"J. Child Psychol. Psychiatry Allied Discip."},{"issue":"3","key":"10.1016\/j.cbi.2019.108840_bib9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/070674371205700302","article-title":"Canadian guidelines for the evidence-based treatment of tic disorders: pharmacotherapy","volume":"57","author":"Pringsheim","year":"2012","journal-title":"Can. J. Psychiatr. Revue canadienne de psychiatrie"},{"issue":"12","key":"10.1016\/j.cbi.2019.108840_bib10","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1440-1754.2004.00491.x","article-title":"Clonidine poisoning in children: a recent experience","volume":"40","author":"Sinha","year":"2004","journal-title":"J. Paediatr. Child Health"},{"issue":"1","key":"10.1016\/j.cbi.2019.108840_bib11","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1097\/MJT.0b013e318293b0e8","article-title":"Use of naloxone for clonidine intoxication in the pediatric age group: case report and review of the literature","volume":"22","author":"Ahmad","year":"2015","journal-title":"Am. J. Therapeut."},{"issue":"10","key":"10.1016\/j.cbi.2019.108840_bib12","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1080\/15563650.2018.1450986","article-title":"Naloxone reversal of clonidine toxicity: dose, dose, dose","volume":"56","author":"Seger","year":"2018","journal-title":"Clin. Toxicol."},{"issue":"10\u201312","key":"10.1016\/j.cbi.2019.108840_bib13","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/15287394.2017.1369915","article-title":"A framework and case studies for evaluation of enzyme ontogeny in children's health risk evaluation","volume":"80","author":"Ginsberg","year":"2017","journal-title":"J. Toxicol. Environ. Health Part A"},{"issue":"7","key":"10.1016\/j.cbi.2019.108840_bib14","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2174\/138920009789895480","article-title":"Genetic polymorphism of the human cytochrome p450 2c9 gene and its clinical significance","volume":"10","author":"Wang","year":"2009","journal-title":"Curr. Drug Metabol."},{"issue":"2","key":"10.1016\/j.cbi.2019.108840_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/03602530902843483","article-title":"Polymorphism of human cytochrome p450 enzymes and its clinical impact","volume":"41","author":"Zhou","year":"2009","journal-title":"Drug Metab. Rev."},{"issue":"2","key":"10.1016\/j.cbi.2019.108840_bib16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2710.2009.01102.x","article-title":"Relationship of cyp2d6 genetic polymorphisms and the pharmacokinetics of tramadol in Chinese volunteers","volume":"35","author":"Li","year":"2010","journal-title":"J. Clin. Pharm. Ther."},{"issue":"3","key":"10.1016\/j.cbi.2019.108840_bib17","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2217\/14622416.10.3.359","article-title":"Novel DNA sequence variations of cytochrome p450 genes in the han Chinese population","volume":"10","author":"Wang","year":"2009","journal-title":"Pharmacogenomics"},{"issue":"9","key":"10.1016\/j.cbi.2019.108840_bib18","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1124\/dmd.110.033878","article-title":"Cyp2d6 mediates 4-hydroxylation of clonidine in vitro: implication for pregnancy-induced changes in clonidine clearance","volume":"38","author":"Claessens","year":"2010","journal-title":"Drug Metab. Dispos.: Biol. Fate Chem."},{"issue":"8","key":"10.1016\/j.cbi.2019.108840_bib19","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1007\/s12325-019-00982-x","article-title":"Impacts of cytochrome p450 2d6*10 allele and a high-fat meal on the pharmacokinetics of dapoxetine in healthy Chinese men: a single-dose, two-treatment study","volume":"36","author":"Tang","year":"2019","journal-title":"Adv. Ther."},{"issue":"8","key":"10.1016\/j.cbi.2019.108840_bib20","first-page":"586","article-title":"Specific cyp 450 genotypes in the Chinese population affect sorafenib toxicity in hbv\/hcv-associated hepatocellular carcinoma patients","volume":"31","author":"Guo","year":"2018","journal-title":"Biomed. Environ. Sci. : BES (Biomed. Environ. Sci.)"},{"issue":"1","key":"10.1016\/j.cbi.2019.108840_bib21","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/ijc.31291","article-title":"The relationship between the cyp2d6 polymorphisms and tamoxifen efficacy in adjuvant endocrine therapy of breast cancer patients in Chinese han population","volume":"143","author":"Lan","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.cbi.2019.108840_bib22","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/bcpt.12478","article-title":"Effects of 22 novel cyp2d6 variants found in the Chinese population on the bufuralol and dextromethorphan metabolisms in vitro","volume":"118","author":"Cai","year":"2016","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.cbi.2019.108840_bib23","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2133\/dmpk.DMPK-11-RV-090","article-title":"In vitro assessment of the allelic variants of cytochrome p450","volume":"27","author":"Hiratsuka","year":"2012","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"11","key":"10.1016\/j.cbi.2019.108840_bib24","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/aps.2013.123","article-title":"In vitro functional characterization of 37 cyp2c9 allelic isoforms found in Chinese han population","volume":"34","author":"Dai","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"issue":"11","key":"10.1016\/j.cbi.2019.108840_bib25","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2165\/11318030-000000000-00000","article-title":"Polymorphism of human cytochrome p450 2d6 and its clinical significance: Part i","volume":"48","author":"Zhou","year":"2009","journal-title":"Clin. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.cbi.2019.108840_bib26","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2174\/1389200215666140202215316","article-title":"Challenges in cyp2d6 phenotype assignment from genotype data: a critical assessment and call for standardization","volume":"15","author":"Hicks","year":"2014","journal-title":"Curr. Drug Metabol."},{"issue":"14","key":"10.1016\/j.cbi.2019.108840_bib27","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.2217\/pgs.13.160","article-title":"Genetic variations of human cyp2d6 in the Chinese han population","volume":"14","author":"Qian","year":"2013","journal-title":"Pharmacogenomics"},{"issue":"1","key":"10.1016\/j.cbi.2019.108840_bib28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome p450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.cbi.2019.108840_bib29","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1517\/17425255.2012.657626","article-title":"Cytochrome p450 variations in different ethnic populations","volume":"8","author":"McGraw","year":"2012","journal-title":"Expert Opin. Drug Metabol. Toxicol."},{"issue":"3","key":"10.1016\/j.cbi.2019.108840_bib30","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1124\/jpet.102.039891","article-title":"Expression, purification, biochemical characterization, and comparative function of human cytochrome p450 2d6.1, 2d6.2, 2d6.10, and 2d6.17 allelic isoforms","volume":"303","author":"Yu","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"11","key":"10.1016\/j.cbi.2019.108840_bib31","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1007\/s12272-015-0646-z","article-title":"Effects of the cyp2d6*10 allele on the pharmacokinetics of atomoxetine and its metabolites","volume":"38","author":"Byeon","year":"2015","journal-title":"Arch Pharm. Res. (Seoul)"},{"issue":"8","key":"10.1016\/j.cbi.2019.108840_bib32","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1124\/dmd.107.015354","article-title":"Comparative metabolic capabilities and inhibitory profiles of cyp2d6.1, cyp2d6.10, and cyp2d6.17","volume":"35","author":"Shen","year":"2007","journal-title":"Drug Metab. Dispos.: the biological fate of chemicals"},{"issue":"1","key":"10.1016\/j.cbi.2019.108840_bib33","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/sj.tpj.6500285","article-title":"Genetic polymorphisms of cytochrome p450 2d6 (cyp2d6): clinical consequences, evolutionary aspects and functional diversity","volume":"5","author":"Ingelman-Sundberg","year":"2005","journal-title":"Pharmacogenomics J."},{"issue":"5","key":"10.1016\/j.cbi.2019.108840_bib34","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2133\/dmpk.DMPK-14-RG-014","article-title":"Functional characterization of wild-type and 49 cyp2d6 allelic variants for n-desmethyltamoxifen 4-hydroxylation activity","volume":"29","author":"Muroi","year":"2014","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.cbi.2019.108840_bib35","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.2147\/DDDT.S106175","article-title":"Role of cytochrome p450 2d6 genetic polymorphism in carvedilol hydroxylation in vitro","volume":"10","author":"Wang","year":"2016","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.cbi.2019.108840_bib36","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.2147\/DDDT.S133814","article-title":"Functional characterization of wild-type and 24 cyp2d6 allelic variants on gefitinib metabolism in vitro","volume":"11","author":"Fang","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"issue":"11","key":"10.1016\/j.cbi.2019.108840_bib37","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1074\/jbc.M511232200","article-title":"Crystal structure of human cytochrome p450 2d6","volume":"281","author":"Rowland","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.cbi.2019.108840_bib38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.dmpk.2016.01.001","article-title":"Effect of cyp2d6 genetic polymorphism on the metabolism of citalopram in vitro","volume":"31","author":"Hu","year":"2016","journal-title":"Drug Metab. Pharmacokinet."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279719311780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279719311780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T19:46:47Z","timestamp":1762112807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279719311780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":38,"alternative-id":["S0009279719311780"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2019.108840","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of 24 CYP2D6 variants found in Chinese population on the metabolism of clonidine in vitro","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2019.108840","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108840"}}